“Molecular-Docking Study of Quinazolin-4(3H)-One Derivatives Against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 12, no. 5, Sept. 2020, pp. 572-5, https://doi.org/10.25004/IJPSDR.2020.120521.